Additional file 1 of Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers

Additional file 1. Materials, Methods, and Abbreviations. Figure S1. Gating strategy of DCs and representative histograms of the surface markers. Figure S2. Immunophenotypes of mouse T cells. Figure S3. Change of individual tumor volume and body weight in mouse models. Figure S4. Immunoblotting analysis in pharmacodynamic study. Figure S5. Additional histopathological analysis of CMT167 tumors.

附加文件1：材料、方法与缩略语。补充图S1：树突状细胞（DCs）的门控策略及表面标志物代表性直方图。补充图S2：小鼠T细胞的免疫表型。补充图S3：小鼠模型中单瘤体积与体质量的变化。补充图S4：药效学研究中的免疫印迹分析。补充图S5：CMT167肿瘤的补充组织病理学分析。